Literature DB >> 579296

[Isolation and characterization of the placental protein pp5 (author's transl)].

H Bohn, W Winckler.   

Abstract

The isolation and characterization of placemental protein PP5 is described. The purification was achieved by use of immunoadsorbents. From the tissue of one human term placenta an average amount of 15 mg PP5 can be extracted. PP5 apparently is specific for the placenta; it could not be detected in extracts from other human tissues. In sera from pregnant women PP5 is not present or only in trace amounts (less than 0.1 mg%). In the ultracentrifuge PP5 was found to have a sedimentation coefficient of 2.8 S and a molecular weight of 36,600 daltons. Electrophoretically the protein migrates as a fast beta1-globulin. The isoelectric point was determined to be 4.6. PP5 is a glycoprotein and contains 19.8% carbohydrates (hexoses 10.0%, hexosamine 4.4%, fucose 0.4%, sialic acid 5.0%). The amino acid composition of the protein is reported, too. PP5 was found to inhibit the activity of trypsin and plasmin; the biological role of this protein therefore may be the inhibition of proteases.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 579296     DOI: 10.1007/bf00667387

Source DB:  PubMed          Journal:  Arch Gynakol        ISSN: 0003-9128


  7 in total

1.  [Isolation of the placental proteins PP2 and its identification as ferritin (author's transl)].

Authors:  H Bohn
Journal:  Arch Gynakol       Date:  1973

Review 2.  [Antigens of the human placenta (author's transl)].

Authors:  H Bohn
Journal:  Klin Wochenschr       Date:  1975-06-15

3.  [Demonstration and characterization of soluble antigens in the human placenta].

Authors:  H Bohn
Journal:  Arch Gynakol       Date:  1972

4.  [Isolation and characterization of a new tissue protein (pp7) from human placentae (author's transl)].

Authors:  H Bohn; W Winckler
Journal:  Arch Gynakol       Date:  1977-01-27

5.  [Comparative studies on placenta specific proteins in man and subhuman primates (author's transl)].

Authors:  H Bohn; H Sedlacek
Journal:  Arch Gynakol       Date:  1975-12-30

6.  [Isolation and characterization of the placental proteil pp1 (author's transl)].

Authors:  H Bohn; W Kraus
Journal:  Arch Gynakol       Date:  1976

7.  [Detection and characterization of pregnancy proteins in the human placenta and their quantitative immunochemical determination in sera from pregnant women].

Authors:  H Bohn
Journal:  Arch Gynakol       Date:  1971-10-28
  7 in total
  9 in total

1.  [Isolation and characterization of a new placenta specific protein (PP12) (author's transl)].

Authors:  H Bohn; W Kraus
Journal:  Arch Gynecol       Date:  1980

2.  [Isolation and characterization of a new placental tissue protein (PP11) (author's transl)].

Authors:  H Bohn; W Winckler
Journal:  Arch Gynecol       Date:  1980

3.  [Isolation and characterization of a new placenta specific protein (PP10) (author's transl)].

Authors:  H Bohn; W Kraus
Journal:  Arch Gynecol       Date:  1979-08

4.  Ectopic synthesis of pregnancy specific beta 1-glycoprotein (SP1) and placental specific tissue proteins (PP5, PP10, PP11, PP12) in nontrophoblastic malignant tumours. Possible markers in oncology.

Authors:  N Inaba; T Renk; K Wurster; W Rapp; H Bohn
Journal:  Klin Wochenschr       Date:  1980-08-01

5.  Placental proteins (SP1, hCG, PP5) and alpha 2-PAG in trophoblastic diseases.

Authors:  G N Than; H Bohn; I F Csaba; D G Szabó; N J Karg; P Göcze
Journal:  Arch Gynecol       Date:  1981

6.  Placental protein 5 (PP5) inhibits thrombin-induced coagulation of fibrinogen.

Authors:  A Meisser; P Bischof; H Bohn
Journal:  Arch Gynecol       Date:  1985

7.  Ectopic production of placenta-"specific" tissue proteins (PP5 and PP11) by malignant breast tumors.

Authors:  N Inaba; T Renk; E Daume; H Bohn
Journal:  Arch Gynecol       Date:  1981

Review 8.  New placental and pregnancy proteins as possible markers in oncology.

Authors:  H Bohn
Journal:  Klin Wochenschr       Date:  1980-05-16

9.  Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.

Authors:  Noriaki Arakawa; Hiroshi Kobayashi; Naohiro Yonemoto; Yusuke Masuishi; Yoko Ino; Hiroshi Shigetomi; Naoto Furukawa; Norihisa Ohtake; Yohei Miyagi; Fumiki Hirahara; Hisashi Hirano; Etsuko Miyagi
Journal:  PLoS One       Date:  2016-10-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.